Alufluoride Q2FY27: consolidated PAT up 91% YoY as margins expand on lower material costs
PAT +91.05% YoY · revenue +16.54% · margins expanding
₹63.89 Cr
+16.54% YoY
₹15.15 Cr
+91.05% YoY
23.24%
+8.9pp YoY
₹19.38
Alufluoride's consolidated revenue rose 16.5% YoY to ₹63.89 Cr (₹54.83 Cr a year ago) and consolidated PAT jumped 91.1% YoY to ₹15.15 Cr (₹7.93 Cr), with basic EPS at ₹19.38 against ₹10.14. Profit outgrowing revenue reflects clear margin expansion: net profit margin widened to 23.2% from 14.4% YoY, and the operating margin to 36.1% from 25.4%, as cost of materials consumed fell to 36.7% of revenue from 49.4% a year earlier — the single biggest driver of the print. Sequentially the swing looks dramatic — PAT up ~452% and revenue up ~140% versus Q1 FY27's ₹2.75 Cr and ₹26.57 Cr — but that compares against a depressed base: Q1 FY27 revenue had fallen 39% YoY and PAT 11.5% YoY on a Fluo-Silicic Acid (FSA) supply crunch, so this quarter reads as recovery from that trough layered on top of genuine YoY growth, not a standalone seasonal spike.
Q2 FY-2027 vs prior quarters
There is no analyst coverage or consensus estimate for this micro-cap (paid-up equity capital of just ₹7.82 Cr) — a web search for a Q2 FY27 preview found none, so the print cannot be benchmarked against street expectations, and management has issued no formal guidance on record either. The filing's notes confirm the Silicic Acid supply issue from the adjacent Fertilizer Complex 'continues to be a problem,' with the company sourcing Fluo-Silicic Acid from costlier distant sources — margin expansion has come despite this unresolved constraint, not because of its resolution. Balance-sheet movement points to a completed capex cycle behind the volume growth: property, plant and equipment rose to ₹92.86 Cr from ₹65.02 Cr (31-Mar-26) as capital work-in-progress fell from ₹22.54 Cr to ₹1.77 Cr, consistent with capitalisation of a capacity expansion. The Board also declared an interim dividend of ₹2.50/share (25% of ₹10 face value), record date November 20, 2026. Standalone and consolidated numbers are closely aligned (standalone PAT ₹15.12 Cr vs consolidated ₹15.15 Cr), confirming the Singapore subsidiary remains immaterial to group results.
The stock went into the print at ₹611.05, down 1.6% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; revenue is at a 6-quarter high.
W1
Whether the newly capitalised capacity (PP&E up to ₹92.86 Cr from ₹65.02 Cr) sustains this volume and margin run-rate into H2 FY27
W2
Silicic Acid sourcing from costlier distant suppliers (filing note) — watch for cost pressure if the adjacent Fertilizer Complex supply issue persists or worsens
W3
Interim dividend of ₹2.50/share, record date Nov 20, 2026 — confirm payment within the stated 30-day window
Clean unaudited quarter; no exceptional items in current or year-ago column. Consolidated includes an immaterial, unreviewed Singapore subsidiary (management-certified H1 revenue ₹1.08 Cr, comprehensive loss ₹0.10 Cr). All figures converted from ₹ Lakhs by dividing by 100.
Informational and educational content only. Not investment advice.